These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia. Mide SM, Huygens P, Bozzini CE, Fernandez Pol JA. In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516 [Abstract] [Full Text] [Related]
4. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109 [Abstract] [Full Text] [Related]
5. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis. Shih LY, Huang JY. Nephron; 1998 Mar; 79(2):142-7. PubMed ID: 9647492 [Abstract] [Full Text] [Related]
6. Increased response of erythroid progenitors to interleukin-3 in sickle cell anemia: CFU-E-like behavior of circulating erythroid progenitors in liquid culture. Isoyama K, Baliga S, Shah A, Mankad VN. Am J Hematol; 1991 Oct; 38(2):101-7. PubMed ID: 1951299 [Abstract] [Full Text] [Related]
11. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure. Biljanović-Paunović L, Djukanović L, Lezaić V, Stojanović N, Marisavljević D, Pavlović-Kentera V. Eur J Med Res; 1998 Dec 16; 3(12):564-70. PubMed ID: 9889177 [Abstract] [Full Text] [Related]
13. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Johnson CS, Cook CA, Furmanski P. Exp Hematol; 1990 Feb 16; 18(2):109-13. PubMed ID: 2303102 [Abstract] [Full Text] [Related]
14. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L. Leukemia; 1990 Nov 16; 4(11):771-4. PubMed ID: 2232891 [Abstract] [Full Text] [Related]
15. Periodical appearance of erythropoietin-independent erythropoiesis in chronic myelogenous leukemia with cyclic oscillation. Umemura T, Hirata J, Kaneko S, Nishimura J, Motomura S, Kozuru M, Ibayashi H. Acta Haematol; 1986 Nov 16; 76(4):230-4. PubMed ID: 3107311 [Abstract] [Full Text] [Related]
16. The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis. Battaglia A, Fattorossi A, Pierelli L, Bonanno G, Marone M, Ranelletti FO, Coscarella A, De Santis R, Bach S, Mancuso S, Scambia G. Exp Hematol; 2000 May 16; 28(5):490-8. PubMed ID: 10812238 [Abstract] [Full Text] [Related]
17. Erythroid progenitor cells (CFU-E*) from Friend virus-infected mice undergo 55Fe suicide in vitro in the absence of added erythropoietin. Del Rizzo DF, Axelrad AA. Exp Hematol; 1985 Nov 16; 13(10):1055-61. PubMed ID: 4054246 [Abstract] [Full Text] [Related]
18. Factors affecting erythroid colony growth (CFU-E) from human marrow. Freedman MH, Saunders EF. Exp Hematol; 1977 Nov 16; 5(4):250-3. PubMed ID: 891664 [Abstract] [Full Text] [Related]
20. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. McGonigle RJ, Boineau FG, Beckman B, Ohene-Frempong K, Lewy JE, Shadduck RK, Fisher JW. J Lab Clin Med; 1985 Apr 16; 105(4):449-58. PubMed ID: 3981057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]